UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Successful treatment of Cogan's syndrome with tocilizumab

Scandinavian journal of rheumatology, 2021-07, Vol.50 (4), p.330-331

2021

Volltextzugriff (PDF)

Chevauchement significatif de caractéristiques inflammatoires et dégénératives à l’imagerie chez les patients atteints de pathologie dégénérative du rachis, d’hyperostose squelettique idiopathique diffuse et de spondylarthrite axiale radiographique

Revue du rhumatisme (Ed. française : 1993), 2023-12, Vol.90, p.A173

2023

Volltextzugriff (PDF)

Real‐life intraclass switch among IL‐17 inhibitors in psoriasis: results from a single‐centre, 24‐week, retrospective study

Journal of the European Academy of Dermatology and Venereology, 2022-11, Vol.36 (11), p.e952-e953

2022

Volltextzugriff (PDF)

Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients

Seminars in arthritis and rheumatism, 2021-02, Vol.51 (1), p.137-143

2021

Volltextzugriff (PDF)

When the low may still be high: the heavy burden of residual psoriasis in difficult‐to‐treat areas despite a low DLQI score among patients under biologics or apremilast: a 5‐year, prospective, case‐control study

Journal of the European Academy of Dermatology and Venereology, 2022-02, Vol.36 (2), p.e145-e147

2022

Volltextzugriff (PDF)

POS0941 IN SPONDYLOARTHRITIS PATIENTS THE PRESENCE OF COMORBIDITIES IS AN INDEPENDENT PREDICTOR OF INSUFFICIENT RESPONSE TO THERAPY WITH BIOLOGIC AGENTS AND TREATMENT DISCONTINUATION

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.733-734

2021

Volltextzugriff (PDF)

OP0299 IN RHEUMATOID ARTHRITIS PATIENTS HIGHER NUMBER OF COMORBIDITIES PREDICTS 6-MONTH INSUFFICIENT RESPONSE TO FIRST BIOLOGIC THERAPY AND EVENTUAL CATEGORIZATION OF THE DISEASE AS DIFFICULT-TO-TREAT

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.184-184

2021

Volltextzugriff (PDF)

FRI0218 Safety of Non Anti-TNF Biologic Agents in Rheumatic Patients with Past Hepatitis B Virus Infection. A Single-Center Real-Life Study

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.511-511

2016

Volltextzugriff (PDF)

Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population

Scandinavian journal of rheumatology, 2017-05, Vol.46 (3), p.180-186

2017

Volltextzugriff (PDF)

AB0006 Assessment of Rheumatoid and Psoriatic Arthritis Susceptibility Loci in A Genetic Homogeneous Population of Greece

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.899-899

2016

Volltextzugriff (PDF)

OP0284 FREQUENCY AND FACTORS ASSOCIATED WITH THE PRESENCE OF ACTIVE INFLAMMATORY AND STRUCTURAL CHANGES IN THE MRI OF SACROILIAC JOINTS: RESULTS FROM A POPULATION-BASED STUDY

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.116-117

2024

Volltextzugriff (PDF)

AB1338 CLINICAL COURSE IN COVID 19 DISEASE IN IMMUNOSUPRESSED PATIENTS DIAGNOSED WITH RHEUMATIC DISEASES

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1899-1900

2023

Volltextzugriff (PDF)

POS0138 EFFICACY AND SAFETY OF BELIMUMAB IN ADULTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: PRELIMINARY RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.289-289

2023

Volltextzugriff (PDF)

AB0930 THE VALUE OF THE CURRENT DIAGNOSTIC TOOLS IN THE DIAGNOSIS OF INFLAMMATORY MYOPATHIES: A MULTICENTRE STUDY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.1681-1682

2023

Volltextzugriff (PDF)

POS0768 PRESENCE OF ANTI-Ro/SSA AUTOANTIBODIES, HYPOCOMPLEMENTEMIA AND PHOTOSENSITIVITY INDICATE INDIVIDUALS WITH CONNECTIVE TISSUE DISEASE FEATURES WHO ARE AT INCREASED RISK FOR TRANSITION TO SYSTEMIC LUPUS ERYTHEMATOSUS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.671-671

2022

Volltextzugriff (PDF)

Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study

Clinical and experimental rheumatology, 2018-01, Vol.36 (1), p.102

2018

Volltextzugriff (PDF)

AB1041 BIOLOGICS IN ADULT’S ONSET STILL’S DISEASE: TREATMENT STRATEGIES AND SAFETY IN SINGLE CENTER COHORT WITH LONG-TERM FOLLOW-UP

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1811-1812

2020

Volltextzugriff (PDF)

POS0580 COMORBIDITY BURDEN IS HIGH IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS STARTING BIOLOGICS AND PREDICTS THE INCIDENCE OF SERIOUS ADVERSE EVENTS DURING THERAPY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.523-523

2021

Volltextzugriff (PDF)

AB0636 Relationship between organ damage and impairment of health-related quality of life in patients with Behçet’s Syndrome: results from a longitudinal extension of the BODI Project

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1445-1445

2022

Volltextzugriff (PDF)

AB0630 Assessment of organ damage accrual in Behçet's Syndrome over 2-year follow-up: results from the BODI Project longitudinal extension

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1442-1442

2022

Volltextzugriff (PDF)

AB0631 Impact of Behçet’s Syndrome on work activity and productivity: results from a sub-analysis of the BODI Project cohort

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1442-1443

2022

Volltextzugriff (PDF)

SAT0330 Lower prevalence but comparable clinical characteristics and prognosis of systemic sclerosis in crete-greece as compared to other european countries: a single center experience

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.896

2017

Volltextzugriff (PDF)

POS1172 GEOGRAPHICAL VARIABILITY OF ORGAN DAMAGE BURDEN IN A LARGE INTERNATIONAL MULTICENTER COHORT OF PATIENTS WITH BEHÇET’S SYNDROME: PRELIMINARY RESULTS OF THE PROBE STUDY

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.918-919

2023

Volltextzugriff (PDF)

In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study

Clinical and experimental rheumatology, 2018-09, Vol.36 (5), p.806

2018

Volltextzugriff (PDF)

FRI0155 Α MULTICENTER “AT-RISK” COHORT FOR THE DISCOVERY OF ENVIRONMENTAL, CLINICAL AND MOLECULAR PREDICTORS FOR THE TRANSITION INTO SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.661-661

2020

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(29)

Sprache

Englisch
(28)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Successful treatment of Cogan's syndrome with tocilizumab

Chevauchement significatif de caractéristiques inflammatoires et dégénératives à l’imagerie chez les patients atteints de pathologie dégénérative du rachis, d’hyperostose squelettique idiopathique diffuse et de spondylarthrite axiale radiographique

Real‐life intraclass switch among IL‐17 inhibitors in psoriasis: results from a single‐centre, 24‐week, retrospective study

Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients

When the low may still be high: the heavy burden of residual psoriasis in difficult‐to‐treat areas despite a low DLQI score among patients under biologics or apremilast: a 5‐year, prospective, case‐control study

POS0941 IN SPONDYLOARTHRITIS PATIENTS THE PRESENCE OF COMORBIDITIES IS AN INDEPENDENT PREDICTOR OF INSUFFICIENT RESPONSE TO THERAPY WITH BIOLOGIC AGENTS AND TREATMENT DISCONTINUATION

OP0299 IN RHEUMATOID ARTHRITIS PATIENTS HIGHER NUMBER OF COMORBIDITIES PREDICTS 6-MONTH INSUFFICIENT RESPONSE TO FIRST BIOLOGIC THERAPY AND EVENTUAL CATEGORIZATION OF THE DISEASE AS DIFFICULT-TO-TREAT

FRI0218 Safety of Non Anti-TNF Biologic Agents in Rheumatic Patients with Past Hepatitis B Virus Infection. A Single-Center Real-Life Study

Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population

AB0006 Assessment of Rheumatoid and Psoriatic Arthritis Susceptibility Loci in A Genetic Homogeneous Population of Greece

OP0284 FREQUENCY AND FACTORS ASSOCIATED WITH THE PRESENCE OF ACTIVE INFLAMMATORY AND STRUCTURAL CHANGES IN THE MRI OF SACROILIAC JOINTS: RESULTS FROM A POPULATION-BASED STUDY

AB1338 CLINICAL COURSE IN COVID 19 DISEASE IN IMMUNOSUPRESSED PATIENTS DIAGNOSED WITH RHEUMATIC DISEASES

POS0138 EFFICACY AND SAFETY OF BELIMUMAB IN ADULTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS: PRELIMINARY RESULTS FROM A PROSPECTIVE OBSERVATIONAL STUDY

AB0930 THE VALUE OF THE CURRENT DIAGNOSTIC TOOLS IN THE DIAGNOSIS OF INFLAMMATORY MYOPATHIES: A MULTICENTRE STUDY

POS0768 PRESENCE OF ANTI-Ro/SSA AUTOANTIBODIES, HYPOCOMPLEMENTEMIA AND PHOTOSENSITIVITY INDICATE INDIVIDUALS WITH CONNECTIVE TISSUE DISEASE FEATURES WHO ARE AT INCREASED RISK FOR TRANSITION TO SYSTEMIC LUPUS ERYTHEMATOSUS

Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study

AB1041 BIOLOGICS IN ADULT’S ONSET STILL’S DISEASE: TREATMENT STRATEGIES AND SAFETY IN SINGLE CENTER COHORT WITH LONG-TERM FOLLOW-UP

POS0580 COMORBIDITY BURDEN IS HIGH IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS STARTING BIOLOGICS AND PREDICTS THE INCIDENCE OF SERIOUS ADVERSE EVENTS DURING THERAPY

AB0636 Relationship between organ damage and impairment of health-related quality of life in patients with Behçet’s Syndrome: results from a longitudinal extension of the BODI Project

AB0630 Assessment of organ damage accrual in Behçet's Syndrome over 2-year follow-up: results from the BODI Project longitudinal extension

AB0631 Impact of Behçet’s Syndrome on work activity and productivity: results from a sub-analysis of the BODI Project cohort

SAT0330 Lower prevalence but comparable clinical characteristics and prognosis of systemic sclerosis in crete-greece as compared to other european countries: a single center experience

POS1172 GEOGRAPHICAL VARIABILITY OF ORGAN DAMAGE BURDEN IN A LARGE INTERNATIONAL MULTICENTER COHORT OF PATIENTS WITH BEHÇET’S SYNDROME: PRELIMINARY RESULTS OF THE PROBE STUDY

In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study

FRI0155 Α MULTICENTER “AT-RISK” COHORT FOR THE DISCOVERY OF ENVIRONMENTAL, CLINICAL AND MOLECULAR PREDICTORS FOR THE TRANSITION INTO SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Suchergebnisse filtern